# Evaluation of the CapScan Device to Measure the Metabolism of Sulfasalazine

> **NCT05749068** · NA · COMPLETED · sponsor: **Envivo Bio Inc** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DEVICE:** CapScan intestinal sampling device

## Key facts

- **NCT ID:** NCT05749068
- **Lead sponsor:** Envivo Bio Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2022-10-15
- **Final completion:** 2022-10-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05749068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05749068, "Evaluation of the CapScan Device to Measure the Metabolism of Sulfasalazine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05749068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*